Kovai Medical Center & Hospital Ltd

Kovai Medical Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Kovai Medical Center & Hospital Ltd

₹ 5,324 -1.89%
01 Feb - close price
kmchhospitals.com BSE: 523323 NSE: KOVAI
About

Kovai Medical Center & Hospital Ltd is a Coimbatore-based company which is in the business of advanced healthcare services. It also forayed into education services in 2019 with the commencement of its new Medical College in Coimbatore.[1]

Key Points

Business Segments

Website BSE NSE
  • Market Cap ₹ 5,824 Cr.
  • Current Price ₹ 5,324
  • High / Low ₹ 6,725 / 4,810
  • Stock P/E 25.5
  • Book Value ₹ 1,088
  • Dividend Yield 0.19 %
  • ROCE 23.3 %
  • ROE 21.2 %
  • Face Value ₹ 10.0
Edit ratios

Pros

Cons

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Healthcare Services Hospital

Part of BSE Healthcare BSE Allcap

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025
252 264 267 275 303 321 321 315 344 355 357 374 392
184 193 200 206 217 225 229 229 248 252 256 268 285
Operating Profit 68 71 67 68 85 96 92 86 96 103 101 106 107
OPM % 27% 27% 25% 25% 28% 30% 29% 27% 28% 29% 28% 28% 27%
3 4 5 6 4 5 6 5 5 6 6 6 6
Interest 10 10 10 10 8 7 7 7 8 9 9 9 9
Depreciation 22 22 22 22 23 23 24 24 24 25 25 26 27
Profit before tax 39 43 41 42 58 71 67 61 67 75 74 76 78
Tax % 23% 27% 25% 26% 26% 25% 22% 25% 25% 23% 26% 25% 24%
30 31 31 31 43 53 52 46 51 58 55 57 59
EPS in Rs 27.67 28.46 27.93 28.38 39.67 48.53 47.69 41.81 46.32 52.82 49.99 52.30 53.79
Raw PDF
Upcoming result date: 6 February 2026

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
334 402 465 531 588 628 712 690 905 1,020 1,220 1,371 1,478
261 307 374 406 459 494 540 495 645 746 874 981 1,061
Operating Profit 73 94 92 125 129 135 171 195 261 274 346 390 417
OPM % 22% 23% 20% 23% 22% 21% 24% 28% 29% 27% 28% 28% 28%
5 7 8 6 7 8 10 12 12 14 21 21 25
Interest 24 20 17 15 13 15 18 33 46 43 37 36 36
Depreciation 16 21 21 24 34 36 52 68 85 89 92 98 102
Profit before tax 37 59 62 92 89 93 112 106 141 155 238 278 304
Tax % 36% 35% 35% 35% 35% 35% 15% 27% 26% 25% 24% 25%
24 39 40 60 58 60 95 78 104 116 180 209 229
EPS in Rs 21.68 35.37 36.95 54.81 52.99 54.96 86.44 71.00 95.28 105.80 164.25 190.96 208.90
Dividend Payout % 7% 4% 7% 5% 6% 5% 3% 4% 6% 9% 6% 5%
Compounded Sales Growth
10 Years: 13%
5 Years: 14%
3 Years: 15%
TTM: 14%
Compounded Profit Growth
10 Years: 18%
5 Years: 17%
3 Years: 26%
TTM: 13%
Stock Price CAGR
10 Years: 20%
5 Years: 35%
3 Years: 46%
1 Year: -2%
Return on Equity
10 Years: 21%
5 Years: 20%
3 Years: 21%
Last Year: 21%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Sep 2025
Equity Capital 11 11 11 11 11 11 11 11 11 11 11 11 11
Reserves 91 127 165 224 276 332 420 499 598 708 878 1,075 1,179
184 163 158 125 202 378 543 623 550 511 310 415 399
65 85 96 103 116 129 134 148 184 209 240 299 328
Total Liabilities 351 386 430 464 605 850 1,108 1,281 1,343 1,439 1,439 1,801 1,917
277 281 337 354 443 469 643 1,033 1,085 1,088 1,118 1,283 1,286
CWIP 5 17 10 6 13 227 300 45 5 23 39 154 224
Investments 4 4 4 4 0 0 0 0 0 0 0 0 0
65 85 78 100 149 153 165 203 253 328 282 364 406
Total Assets 351 386 430 464 605 850 1,108 1,281 1,343 1,439 1,439 1,801 1,917

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
68 97 85 99 87 126 166 186 262 263 344 353
-12 -80 -113 -83 -192 -352 -349 -180 -292 -358 -290 -612
-52 -43 -24 -50 60 160 113 38 -119 -86 -243 62
Net Cash Flow 4 -26 -53 -33 -45 -66 -70 44 -149 -180 -189 -197

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 8 9 7 8 8 6 4 7 8 8 5 8
Inventory Days 33 25 22 20 23 20 23 19 19 18 17 16
Days Payable 35 53 47 37 43 47 46 29 20 35 30 29
Cash Conversion Cycle 6 -19 -19 -9 -12 -21 -19 -2 6 -9 -7 -5
Working Capital Days -48 -60 -56 -50 -48 -55 -39 -56 -49 -48 -49 -57
ROCE % 21% 27% 25% 31% 24% 18% 15% 13% 16% 17% 23% 23%

Shareholding Pattern

Numbers in percentages

2 Recently
Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
55.98% 56.26% 56.43% 56.44% 56.47% 56.50% 56.51% 56.55% 56.55% 56.55% 56.52% 56.53%
2.18% 2.20% 2.25% 2.24% 0.34% 0.32% 0.44% 0.55% 1.10% 1.27% 1.25% 1.31%
2.07% 2.19% 2.09% 2.09% 4.18% 4.28% 4.37% 4.43% 4.03% 4.52% 4.89% 4.73%
39.79% 39.34% 39.24% 39.24% 39.02% 38.91% 38.67% 38.46% 38.32% 37.65% 37.34% 37.43%
No. of Shareholders 9,67410,48710,73010,33811,91813,14714,80015,95117,08617,65018,68118,644

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings